Bank Of Montreal Myriad Genetics Inc Transaction History

Bank Of Montreal

$192 Billion
Q1 2025

A detailed history of Bank Of Montreal transactions in Myriad Genetics Inc stock. As of the latest transaction made, Bank Of Montreal holds 16,164 shares of MYGN stock, worth $81,628. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,164

Previous 12,998 24.36%

Holding current value

$81,628

Previous $178,000 19.66%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$8.87 - $14.98 $28,082 - $47,426	3,166 Added 24.36%	16,164 $143,000
Q4 2024 Feb 13, 2025	BUY	$13.17 - $27.03 $6,110 - $12,541	464 Added 3.7%	12,998 $178,000
Q3 2024 Nov 13, 2024	SELL	$23.97 - $28.6 $3,259 - $3,889	-136 Reduced 1.07%	12,534 $343,000
Q2 2024 Aug 14, 2024	SELL	$17.98 - $25.47 $9,295 - $13,167	-517 Reduced 3.92%	12,670 $309,000
Q1 2024 May 13, 2024	SELL	$17.59 - $23.59 $1.49 Million - $2 Million	-84,631 Reduced 86.52%	13,187 $281,000
Q4 2023 Feb 08, 2024	BUY	$13.91 - $21.32 $1.19 Million - $1.83 Million	85,764 Added 711.5%	97,818 $1.87 Million
Q3 2023 Nov 01, 2023	SELL	$15.99 - $23.22 $2.93 Million - $4.25 Million	-183,238 Reduced 93.83%	12,054 $193,000
Q2 2023 Aug 02, 2023	BUY	$17.56 - $23.76 $3.22 Million - $4.36 Million	183,398 Added 1541.94%	195,292 $4.53 Million
Q1 2023 Jun 13, 2024	BUY	$15.26 - $23.75 $16,114 - $25,080	1,056 Added 8.01%	14,243 $330,000
Q4 2022 Feb 01, 2023	SELL	$14.51 - $20.99 $9,416 - $13,622	-649 Reduced 5.17%	11,894 $172,000
Q3 2022 Nov 10, 2022	SELL	$18.21 - $27.88 $681,618 - $1.04 Million	-37,431 Reduced 74.9%	12,543 $281,000
Q2 2022 Aug 11, 2022	SELL	$16.45 - $25.88 $254,711 - $400,725	-15,484 Reduced 23.65%	49,974 $1.07 Million
Q1 2022 May 12, 2022	BUY	$22.67 - $28.01 $885,308 - $1.09 Million	39,052 Added 147.89%	65,458 $1.69 Million
Q4 2021 Feb 11, 2022	SELL	$24.13 - $32.63 $71,062 - $96,095	-2,945 Reduced 10.03%	26,406 $737,000
Q3 2021 Nov 12, 2021	SELL	$29.97 - $36.66 $78,311 - $95,792	-2,613 Reduced 8.17%	29,351 $947,000
Q2 2021 Aug 12, 2021	BUY	$25.39 - $32.61 $811,565 - $1.04 Million	31,964 New	31,964 $980,000

Others Institutions Holding MYGN

# of Institutions

240

Shares Held

95.3M

Call Options Held

95.4K

Put Options Held

18.2K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $407M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account